Photodynamic therapy for treatment subretinal neovascularization

Sergey E. Avetisov; Maria V. Budzinskaja; Tatyana N. Kiseleva; Natalia V. Balatskaya; Irina V. Gurova; Viktor B. Loschenov; Sergey A. Shevchik; Sergey G. Kuzmin; Georgy N. Vorozhtsov

doi:10.1117/12.730392

13 July 2007 Photodynamic therapy for treatment subretinal neovascularization

Sergey E. Avetisov, Maria V. Budzinskaja, Tatyana N. Kiseleva, Natalia V. Balatskaya, Irina V. Gurova, Viktor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, Georgy N. Vorozhtsov

Author Affiliations +

Proceedings Volume 6632, Therapeutic Laser Applications and Laser-Tissue Interactions III; 663212 (2007) https://doi.org/10.1117/12.730392
Event: European Conferences on Biomedical Optics, 2007, Munich, Germany

Abstract

This work are devoted our experience with photodynamic therapy (PDT) with <<Photosens>> for patients with choroidal neovascularization (CNV). 18 patients with subfoveal CNV in age-related macular degeneration (AMD), 24 patients with subfoveal CNV in pathological myopia (PM) and 4 patients with subfoveal CNV associated with toxoplasmic retinochoroiditis were observed. CNV was 100% classic in all study patients. Standardized protocol refraction, visual acuity testing, ophthalmologic examinations, biomicroscopy, fluorescein angiography, and ultrasonography were performed before treatment and 1 month, 3 months, 6 months, and 1 year after treatment; were used to evaluate the results of photodynamic therapy with <<Photosens>> (0.02% solution of mixture sulfonated aluminium phtalocyanine 0.05 mg/kg, intravenously). A diode laser (<<Biospec>>, Inc, Moscow) was used operating in the range of 675 nm. Need for retreatment was based on fluorescein angiographic evidence of leakage at 3-month follow-up intervals. At 3, 6, 9 month 26 (56.5%) patients had significant improvement in the mean visual acuity. At the end of the 12-month minimal fluorescein leakage from choroidal neovascularization was seen in 12 (26.1%) patients and the mean visual acuity was slightly worse than 0.2 which was not statistically significant as compared with the baseline visual acuity. Patients with fluorescein leakage from CNV underwent repeated PDT with <<Photosens>>. 3D-mode ultrasound shown the decreasing thickness of chorioretinal complex in CNV area. Photodynamic therapy with <<Photosens>> can safely reduce the risk of severe vision loss in patients with predominantly classic subfoveal choroidal neovascularization secondary to AMD, PM and toxoplasmic retinochoroiditis.

Citation Download Citation

Sergey E. Avetisov, Maria V. Budzinskaja, Tatyana N. Kiseleva, Natalia V. Balatskaya, Irina V. Gurova, Viktor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, and Georgy N. Vorozhtsov "Photodynamic therapy for treatment subretinal neovascularization", Proc. SPIE 6632, Therapeutic Laser Applications and Laser-Tissue Interactions III, 663212 (13 July 2007); https://doi.org/10.1117/12.730392

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
6 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Photodynamic therapy

Angiography

Eye

Visualization

Luminescence

Phase modulation

Ultrasonography

Show All Keywords

Keywords/Phrases

Search In:

Publication Years